Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that ...

Cancer treatments can instigate ocular surface disease and other deleterious ocular side effects that optometrists can oversee and manage.

Pars plana vitrectomy is a safe and effective surgery that is essential in the treatment of a variety of posterior segment ...

This valuable study combines real-time keypoint tracking with transdermal activation of sensory neurons to investigate sensory neuron recruitment in freely moving mice, and builds on the authors' ...

HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction.

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The novice would then promise to sacrifice personal interests for the good of the society. The ‘Eye of Providence’ – a symbol resembling an eye inside a triangle – appears on churches around the globe ...

The pediatric trial compared Dextenza with prednisolone acetate suspension eye drops as a treatment ... reported with Dextenza include anterior chamber inflammation and elevations in intraocular ...

Eye drops you can buy over the counter may be a good option if you have a mild case of dry eye, as long as you follow the labeling. Some drops may contain chemicals that can cause side effects ...

With only one more concert to go, the Reno Chamber Orchestra rounds out their 50 th season this spring. On Sunday, at UNR’s Nightingale Concert Hall, audiences were treated to an afternoon of a few ...

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date ...